0001209191-18-003113.txt : 20180110 0001209191-18-003113.hdr.sgml : 20180110 20180110161148 ACCESSION NUMBER: 0001209191-18-003113 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180108 FILED AS OF DATE: 20180110 DATE AS OF CHANGE: 20180110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GROENHUYSEN WILHELMUS CM CENTRAL INDEX KEY: 0001264783 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 18521640 MAIL ADDRESS: STREET 1: C/O NAVTEQ CORPORATION STREET 2: 222 MERCHANDISE MART STE 900 CITY: CHICAGO STATE: IL ZIP: 60654 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Novocure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-08 0 0001645113 Novocure Ltd NVCR 0001264783 GROENHUYSEN WILHELMUS CM C/O NOVOCURE INC., 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Financial Officer Ordinary Shares 2018-01-08 4 A 0 310 15.045 A 240210 D Ordinary Shares 2018-01-09 4 S 0 31132 21.0194 D 209078 D The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2017 through December 31, 2017. This transaction is also exempt under Rule 16b-3(c). In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 3, 2017. On January 9, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 31,132 shares in multiple trades at prices ranging from $21.00 to $21.05. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. /s/ Todd Longsworth, Attorney in fact for Wilhelmus CM Groenhuysen 2018-01-10